Former Executive Vice President, Chief Legal Officer and Secretary · Alaunos Therapeutics, Inc. (TCRT)

Caesar Belbel

A named executive officer of Alaunos Therapeutics in every fiscal year CompBrief holds from FY2016 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$827,739

Salary $71,513Stock awards $0Bonus $47,260

FY2017: $1,066,050

3rd of 5 named executive officers at Alaunos Therapeutics by FY2018 total.

5 named officers on file for Alaunos Therapeutics, FY2018

Caesar Belbel’s pay file — $29

  • 3 fiscal years of pay, line by line
  • TCRT’s disclosed peer group of 1 company

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Alaunos Therapeutics’s whole pay program stands against its peers

  • Alaunos Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TCRT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2019 (DEF 14A).

Free

Get Caesar Belbel’s full pay file as a PDF — free

More than this page: up to 10 years of Caesar’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Caesar Belbel compensation by year

Alaunos Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Alaunos Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018
Salary$375,000$375,000$71,513
Bonus$262,500$328,125$47,260
Stock awards$504,773$360,180$0
Option awards$0$0$0
Non-equity incentive$0$0$0
Pension and deferred compensation$0$0$0
All other$2,713$2,745$708,966
Total$1,144,986$1,066,050$827,739

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Alaunos Therapeutics, Inc. DEF 14A filed April 29, 2019, accession 0001193125-19-125377, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Alaunos Therapeutics, Inc. filed document, accession 0001193125-19-125377. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2019.

$1.1M
$1.1M
$828K
FY16
FY17
FY18
SalaryBonusStock awardsAll other

Alaunos Therapeutics’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Laurence CooperChief Executive Officer$1,589,239
Robert HadfieldExecutive Vice President, General Counsel and Secretary$836,091
Caesar Belbel · this pageFormer Executive Vice President, Chief Legal Officer and Secretary$827,739
David MauneyPresident$608,756
Kevin LafondSr. Vice President – Finance, Chief Accounting Officer and Treasurer$398,998

The full Alaunos Therapeutics compensation record

free company brief

This page is one person within Alaunos Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Alaunos Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Alaunos Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Caesar Belbel's compensation dossier · One-time report. No refunds.